Immunopharmacological Effects of Rituximab in Atopic Dermatitis

NCT00267826 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Rituximab

Sponsor

University of Bern

Collaborators

[object Object]
[object Object]